BioLineRx Ltd. (BLRX) Q1 2026 Earnings Call Transcript
Source: SeekingAlpha
2026-05-27 10:47:04 ET
BioLineRx Ltd. (BLRX) Q1 2026 Earnings Call May 27, 2026 8:30 AM EDT
Company Participants
Philip Serlin - Chief Executive Officer
Mali Zeevi - Chief Financial Officer
Ella Sorani - Chief Development Officer
...
Read the full article on Seeking Alpha
For further details see:
BioLineRx Ltd. (BLRX) Q1 2026 Earnings Call Transcript
BioLineRx Ltd.
NASDAQ: BLRX
BLRX Trading
-4.98% G/L:
$2.86 Last:
27,222 Volume:
$2.91 Open:
BLRX Latest News
July 08, 2026 07:00:00 am
BioLineRx and Hemispherian Announce New Preclinical Data Demonstrating Strong Synergistic Effect between GLIX1 and PARP Inhibitor in a Patient-Derived Ovarian Cancer Xenograft Model
May 27, 2026 07:00:00 am
BioLineRx Reports First Quarter 2026 Financial Results and Provides Corporate Update
$11,716,322
3,337,740
N/A
8
N/A
Biotechnology & Life Sciences
Healthcare
IL
Modi'in
